CLINICAL_TRIALS
trial_result
· 2016-08-01
Clinical Trial Update: A Study of Vemurafenib in Metastatic Melanoma Participants With Brain Metastases [Phase 2]
Summary
A Phase 2 study of vemurafenib in metastatic melanoma, including patients with brain metastases, has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2016-08-01